About: http://data.cimple.eu/news-article/dde7d16b2fa2eb4bea9ae7c06eed44e4c71b5a9bba88d7bc32fb96a8

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/dde7d16b2fa2eb4bea9ae7c06eed44e4c71b5a9bba88d7bc32fb96a8 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Germany on Monday halted the use of AstraZeneca's coronavirus vaccine after reported blood clotting incidents in Europe, saying that a closer look was necessary. "After new reports of thromboses of the cerebral veins in connection with the vaccination in Germany and Europe, the PEI considers further investigations to be necessary," the health ministry said, referring to a recommendation by the country's vaccine authority, the Paul Ehrlich Institute. "The European Medicines Agency EMA will decide whether and how the new findings will affect the approval of the vaccine," it added. Several European countries, including Ireland and the Netherlands, have suspended usage of the shots, which were jointly developed with the University of Oxford. German Health Minister Jens Spahn said seven cases of cerebral vein thrombosis had been reported, and that while this is a "very low risk" compared to the 1.6 million jabs already given in the country, it would be above average if confirmed to be linked to the vaccine. "The decision today is a purely precautionary measure," said Spahn, adding that he hoped EU medicines regulator EMA would deliver guidance within the week after examining the cases. Both the British-Swedish company and Oxford have said there was no link between their vaccine and blood clotting. AstraZeneca had said at the weekend that the 15 incidences of deep vein thrombosis (DVT) and 22 events of pulmonary embolism reported among those given the vaccine was "much lower than would be expected to occur naturally in a general population". The vaccine has been widely used in Britain's inoculation campaign, but in the European Union, a rollout using the jabs has been slowed down by delivery problems. hmn/dlc/txw
schema:headline	Germany halts AstraZeneca jabs over reported clot risks: ministry
schema:mentions	Inoculation Embolism Paul Ehrlich Institute Thrombosis European Medicines Agency Republic of Ireland Jens Spahn University of Oxford Netherlands AstraZeneca Germany European Union Vaccine United States Severe acute respiratory syndrome coronavirus 2 Cerebral veins Deep vein thrombosis
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-03-15 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	negative sentiment
http://data.cimple...readability_score	86 (xsd:integer)
http://data.cimple...entionsConspiracy	antivax conspiracy theory

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 5 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software